Sofinnova
Startup rounds since 2012 with a Sofinnova investor on the board, and the firm's own fund filings.
Raises
54
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
4
fund filings under the firm's name
Rounds
- Quanta Therapeutics, Inc.$76.2M
- Seaport Therapeutics, Inc.$226M
- OrsoBio, Inc.$40M
- Marea Therapeutics, Inc.$65.4M
- Alumis Inc.$129M
- BioAge Labs, Inc.$194M
- OrsoBio, Inc.$84.6M
- Atsena Therapeutics, Inc.$24.5M
- Quanta Therapeutics, Inc.$30M
- ArriVent Biopharma, Inc.$110M
- RayzeBio, Inc.$168M
- Mineralys Therapeutics, Inc.$118M
- Quanta Therapeutics, Inc.$40.2M
- Vera Therapeutics, Inc.$70.7M
- Bolt Biotherapeutics, Inc.$93.5M
- Syros Pharmaceuticals, Inc.$90.5M
- Chinook Therapeutics U.S., Inc.$115M
- Aerovate Therapeutics, Inc.$75.8M
- Checkmate Pharmaceuticals, Inc.$85.1M
- Inozyme Pharma, Inc.$67.4M
- Checkmate Pharmaceuticals, Inc.$10M
- Passport Systems Inc$20.7M
- E-Circuit Motors, Inc.$4.82M
- Checkmate Pharmaceuticals, Inc.$16M
- Amplyx Pharmaceuticals, Inc.$91.3M
- Aeovian Pharmaceuticals, Inc.$18.8M
- Checkmate Pharmaceuticals, Inc.$22M
- E-Circuit Motors, Inc.$1.09M
- Galera Therapeutics, Inc.$70.2M
- Principia Biopharma Inc.$50M
- Pionyr Immunotherapeutics, Inc.$7M
- Syros Pharmaceuticals, Inc.$11.4M
- Pionyr Immunotherapeutics, Inc.$38M
- E-Circuit Motors, Inc.$2.49M
- Apellis Pharmaceuticals, Inc.$20M
- Checkmate Pharmaceuticals, Inc.$27M
- Checkmate Pharmaceuticals, Inc.$25M
- Dauntless 1, Inc.$8M
- Dauntless 2, Inc.$6.05M
- Effector Therapeutics, Inc.$56M
- Aclaris Therapeutics, Inc.$40M
- Principia Biopharma Inc.$15.3M
- Catalyst Biosciences Inc$1.89M
- First Aid Beverages, Inc.$20.3M
- Mirna Therapeutics, Inc.$41.8M
- Catalyst Biosciences Inc$3.22M
- Aclaris Therapeutics, Inc.$10.6M
- Aerie Pharmaceuticals Inc$125M
- Spark Therapeutics, Inc.$72.8M
- Sorbent Therapeutics Inc$6.5M
- Catalyst Biosciences Inc$5.01M
- Versartis, Inc.$55M
- Versartis, Inc.$10M
- CEBIX Inc$8.8M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 0 |
| 2024 | 5 | — |
| 2023 | 3 | — |
| 2022 | 3 | — |
| 2021 | 3 | — |
| 2020 | 10 | — |
| 2019 | 2 | — |
| 2018 | 5 | — |
| 2017 | 7 | — |
| 2016 | 1 | — |
| 2015 | 6 | — |
| 2014 | 7 | — |
| 2012 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Sofinnova Venture Partners XII, L.P. | 22 Jun 2026 | $550M | $527M |
| Sofinnova Venture Partners XI, L.P. | 11 Sep 2023 | $500M | $500M |
| Sofinnova Venture Partners X, L.P. | 23 Aug 2016 | $650M | $596M |
| Sofinnova Venture Partners IX, L.P. | 10 Jul 2014 | $500M | — |
Listed because a Sofinnova fund's filing names a director of each company. A name match is not a verified identity.